The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients

Disease Markers

Volumn 34, Issue 4, 2013, Pages 237-246

  Aydoǧdu, Müge ^a   Gürsel, Gül ^a   Sancak, Banu ^a   Yeni, Serpil ^a   Sari, Gülçin ^a   Taşyürek, Seçil ^a   Türk, Murat ^a   Yüksel, Seher ^a   Senes, Mehmet ^b   Özis, Türkan Nadir ^c  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ANKARA OCCUPATIONAL DISEASES HOSPITAL   (Turkey)

Author keywords

Acute kidney injury; biomarkers; Cystatin C; human; Intensive Care Units; NGAL protein; predictive value of tests; sepsis

Indexed keywords

CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMORBIDITY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIALYSIS; EARLY DIAGNOSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KIDNEY DYSFUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; URINALYSIS;

EID: 84876224352     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/740351     Document Type: Article

References (34)

1. Cole L, Bellomo R, Silvester W et al. A Prospective multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 2000; 162: 191-196. (Pubitemid 30469819)
2. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813-818. (Pubitemid 41175724)
3. Gursel G, Demir N. Risk factors for acute renal failure in patients with ventilator associated pneumonia. Nephrology (Carlton) 2006; 11(3): 159-64. (Pubitemid 43829433)
4. Hoste EA, Clermont G, Kertsen A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10: R 73.
5. Bellomo R, Ronco C, Kellum JA, et al. The ADQI workgroup. Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: 2nd International Consensus Conference of the ADQI Group. Crit Care 2004; 8: R204-12.
6. Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin like biomarker for human acute kidney injury. Nephrology 2010; 15: 419-428.
7. Moore E, Bellomo R, Nichol A. Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anesthesiol 2010; 76: 425-440.
8. Shemesh O, Golbetz H, Kriss JP, et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838. (Pubitemid 16156326)
9. Doi K, Peter ST, Eisner C, et al. Reduced production of creatinine limits its use as a marker of kidney injury in sepsis. J Am Soc Nephrol 2009; 20: 1217-21.
10. Tuladhar SM, Puntmann VO, Soni M, et al. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009; 53: 261-6.
11. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res 2007; 30: 408-15. (Pubitemid 350191437)
12. Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 2009; 47: 79-82.
13. Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care 2007; 11: R84.
14. Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney International 2011; 79: 1119-1130.
15. Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase associated lipocalin in septic versus nonseptic acute kidney injury in critical illness. Int. Care Med. 2010; 36: 452-61.
16. Constantin J-M, Futier E, Perbet S et al. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: A prospective study. J. Crit. Care 2009; 25: 176. e1-6.
17. Martensson J, Bell M, Oldner A, et al. Neutrophil gelatinaseassociated lipocalin in adult septic patients with and without acute kidney injury. Intensive CareMed 2010; 36: 1333-1340.
18. Kümpers P, Hafer C, Lukasz A, et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010; 14: R9.
19. Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil geletinase associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008; 36: 1297-1303. (Pubitemid 351482681)
20. Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010; 36: 444-51.
21. Villa P, Jimenez M, Soriano M, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005; 9: R139-R143.
22. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148: 810-9. (Pubitemid 351786928)
23. Cockcroft DW, Gault MH. Prediction of creatinine clerance from serum creatinine, Nephron 1976; 16: 31-41.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002; 39 (2Suppl 1): S1-266.
25. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
26. Calandra T., Cohen J., for the International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definition of infections in intensive care unit. Crit Care Med. 2005; 33: 1538-1548. (Pubitemid 40980610)
27. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985, 13: 818-829. (Pubitemid 15250137)
28. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-710. (Pubitemid 26254283)
29. Fine MJ, Auble TE,Yealy DM, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250. (Pubitemid 27044625)
30. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-83. (Pubitemid 17055592)
31. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med 2008; 36: (suppl); S159-S165. (Pubitemid 351483046)
32. Schrier RW, Wang W. Acute renal failure and sepsis. N Eng J Med 2004; 351: 159-69.
33. Nejat M, Pickering JW, Walker RJ et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010; 25: 3283-3289.
34. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421. (Pubitemid 38406982)